cilengitide has been researched along with transforming growth factor beta in 2 studies
| Studies (cilengitide) | Trials (cilengitide) | Recent Studies (post-2010) (cilengitide) | Studies (transforming growth factor beta) | Trials (transforming growth factor beta) | Recent Studies (post-2010) (transforming growth factor beta) |
|---|---|---|---|---|---|
| 194 | 29 | 133 | 49,119 | 560 | 17,610 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Roth, P; Silginer, M; Weller, M; Ziegler, U | 1 |
| Bunse, L; Burghardt, I; Gramatzki, D; Hao, N; Leske, H; Platten, M; Roth, P; Rushing, EJ; Silginer, M; Weller, M | 1 |
2 other study(ies) available for cilengitide and transforming growth factor beta
| Article | Year |
|---|---|
Integrin inhibition promotes atypical anoikis in glioma cells.
Topics: Animals; Anoikis; Apoptosis; Cell Adhesion; Cell Line, Tumor; Down-Regulation; Glioma; Humans; Integrins; Mice; Peptides, Cyclic; Snake Venoms; Transforming Growth Factor beta | 2014 |
The aryl hydrocarbon receptor links integrin signaling to the TGF-β pathway.
Topics: Animals; Animals, Newborn; Antibodies, Neutralizing; Brain Neoplasms; Cell Line, Tumor; Cells, Cultured; Glioblastoma; Hepatocytes; Humans; Immunoblotting; Immunohistochemistry; Integrins; Mice, Inbred C57BL; Mice, Knockout; Naphthyridines; Peptides, Cyclic; Receptors, Aryl Hydrocarbon; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Signal Transduction; Snake Venoms; Sulfonamides; Transforming Growth Factor beta | 2016 |